| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4025947 | Ophthalmology | 2014 | 7 Pages |
Abstract
Patients receiving intravitreal bevacizumab injection every 4 months after plaque radiotherapy for uveal melanoma demonstrated OCT-evident macular edema, clinically evident radiation maculopathy, moderate vision loss, and poor visual acuity less frequently over a period of 2 years than patients not receiving the injections.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Sanket U. MD, Carol L. MD, Carlos G. MD, Juan MD, Saad A. MD, Emil Anthony T. MD, Josep MD, Arman MD, Jerry A. MD,